A citation-based method for searching scientific literature

Rajesha Rupaimoole, Frank J Slack. Nat Rev Drug Discov 2017
Times Cited: 1925



Nico van Zandwijk, Nick Pavlakis, Steven C Kao, Anthony Linton, Michael J Boyer, Stephen Clarke, Yennie Huynh, Agata Chrzanowska, Michael J Fulham, Dale L Bailey, Wendy A Cooper, Leonard Kritharides, Lloyd Ridley, Scott T Pattison, Jennifer MacDiarmid, Himanshu Brahmbhatt, Glen Reid. Lancet Oncol 2017
Times Cited: 248




List of shared articles



Times cited

The Role of MiRNA in Cancer: Pathogenesis, Diagnosis, and Treatment.
Erez Uzuner, Gizem Tugçe Ulu, Sevim Beyza Gürler, Yusuf Baran. Methods Mol Biol 2022
0

RNA in cancer.
Gregory J Goodall, Vihandha O Wickramasinghe. Nat Rev Cancer 2021
106

Dysregulated miR-137 and its target EGFR contribute to the progression of pituitary adenomas.
Dong Wei, Zhang Yu, Yue Cheng, Huang Jiawei, Gao Jian, Gao Hua, Dong Guilan. Mol Cell Endocrinol 2021
0

Hypoxia downregulated miR-4521 suppresses gastric carcinoma progression through regulation of IGF2 and FOXM1.
Shan Xing, Zhi Tian, Wenying Zheng, Wenjuan Yang, Nan Du, Yixue Gu, Jiang Yin, Hao Liu, Xiaoting Jia, Donglan Huang,[...]. Mol Cancer 2021
4

microRNAs Promoting Growth of Gastric Cancer Xenografts and Correlation to Clinical Prognosis.
Ulrich H Weidle, Fabian Birzele, Adam Nopora. Cancer Genomics Proteomics 2021
3

Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment.
Rebecca Raue, Ann-Christin Frank, Shahzad Nawaz Syed, Bernhard Brüne. Int J Mol Sci 2021
2

Non-Coding RNAs in Cancer Diagnosis and Therapy: Focus on Lung Cancer.
Patricia Le, Giulia Romano, Patrick Nana-Sinkam, Mario Acunzo. Cancers (Basel) 2021
1

Recent Advances in Oligonucleotide Therapeutics in Oncology.
Haoyu Xiong, Rakesh N Veedu, Sarah D Diermeier. Int J Mol Sci 2021
8

MicroRNA-206 suppresses mesothelioma progression via the Ras signaling axis.
Anand Singh, Nathanael Pruett, Roma Pahwa, Arushi P Mahajan, David S Schrump, Chuong D Hoang. Mol Ther Nucleic Acids 2021
1